ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
67 hedge funds and large institutions have $82.5M invested in Oncternal Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 14 closing their positions.
Holders
67
Holders Change
+13
Holders Change %
+24.07%
% of All Funds
1.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
18
Reduced
12
Closed
14
Calls
$1.41M
Puts
$2.85M
Net Calls
-$1.44M
Net Calls Change
-$1.51M
Top Buyers
1 |
1
Invesco
Atlanta,
Georgia
|
$7.97M |
2 |
2
BlackRock
New York
|
$8.95M |
3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$4.17M |
4 |
4
Ameriprise
Minneapolis,
Minnesota
|
$3.62M |
5 |
PHP
5
Parkman Healthcare Partners
Stamford,
Connecticut
|
$6.48M |